Transcatheter aortic valve implantation (TAVI) has recently emerged as a treatment option for patients with severe aortic valve stenosis (AS). For patients who are deemed inoperable for surgical aortic valve replacement (SAVR), TAVI has a significant mortality benefit compared to medical therapy. This review discusses established and emerging roles for multimodality imaging and focuses on the application of these technologies for patient selection, intraprocedural guidance, and the detection and quantification of acute and chronic complications of this novel procedure.
Keywords: CT angiography; Edwards SAPIEN; Medtronic CoreValve; Medtronic CoreValve U.S. Pivotal Trial; TAVI; TAVR; aortic stenosis; cardiac magnetic resonance; surgical aortic valve replacement; transcatheter aortic valve implantation; transesophageal echocardiography.